72 | 20-hydroxy-5,8,11,14-eicosatetraenoic acidIBA
01/2023
-
08/2002 |
62 | AcidsIBA
05/2024
-
10/2004 |
45 | Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
05/2024
-
07/2004 |
22 | Arachidonic Acid (Vitamin F)IBA
01/2021
-
07/2004 |
16 | EicosanoidsIBA
01/2023
-
01/2007 |
13 | EnzymesIBA
05/2024
-
04/2005 |
12 | AndrogensIBA
01/2023
-
12/2004 |
12 | Proteins (Proteins, Gene)FDA Link
01/2022
-
12/2005 |
12 | Epoxide HydrolasesIBA
01/2019
-
04/2005 |
12 | Cytochrome P-450 CYP4A (Alkane 1 Monooxygenase)IBA
01/2019
-
07/2004 |
11 | Hydroxyeicosatetraenoic Acids (HETE)IBA
01/2023
-
04/2005 |
11 | Angiotensin IIIBA
01/2022
-
02/2010 |
11 | 14,15-epoxy-5,8,11-eicosatrienoic acidIBA
10/2019
-
10/2005 |
11 | Mixed Function Oxygenases (Monooxygenases)IBA
11/2018
-
10/2004 |
9 | HET0016IBA
01/2019
-
02/2005 |
9 | SodiumIBA
12/2017
-
06/2006 |
9 | SaltsIBA
01/2016
-
06/2006 |
8 | Vasoconstrictor AgentsIBA
12/2019
-
02/2004 |
7 | Glycine (Aminoacetic Acid)FDA LinkGeneric
01/2022
-
03/2009 |
7 | LipopolysaccharidesIBA
01/2022
-
03/2009 |
7 | Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2020
-
08/2002 |
6 | LipidsIBA
05/2024
-
01/2012 |
6 | Messenger RNA (mRNA)IBA
08/2021
-
12/2005 |
6 | CytochromesIBA
01/2021
-
10/2004 |
6 | cytochrome P-450 CYP2C subfamilyIBA
11/2018
-
06/2007 |
5 | Insulin (Novolin)FDA Link
05/2024
-
11/2018 |
5 | N-(20-hydroxyeicosa-5,14-dienoyl)glycineIBA
01/2022
-
04/2013 |
5 | CytokinesIBA
12/2019
-
01/2012 |
5 | ReninIBA
10/2018
-
12/2009 |
5 | Antihypertensive Agents (Antihypertensives)IBA
01/2018
-
01/2014 |
5 | AngiotensinsIBA
10/2017
-
01/2010 |
5 | N- methylsulfonyl- 6- (2- propargyloxyphenyl)hexanamideIBA
01/2014
-
12/2004 |
5 | Vasodilator Agents (Vasodilators)IBA
07/2013
-
07/2005 |
5 | 11,12-epoxy-5,8,14-eicosatrienoic acidIBA
06/2010
-
12/2005 |
4 | Glucose (Dextrose)FDA LinkGeneric
05/2024
-
10/2017 |
4 | EET-BIBA
01/2019
-
11/2013 |
4 | DDMSIBA
01/2016
-
10/2004 |
4 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2016
-
09/2011 |
4 | Acetylcholine (Acetylcholine Chloride)FDA Link
01/2014
-
07/2005 |
4 | ProstaglandinsIBA
07/2013
-
07/2005 |
4 | Adenosine Triphosphate (ATP)IBA
03/2007
-
08/2002 |
3 | G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2022
-
05/2017 |
3 | LigandsIBA
01/2021
-
06/2007 |
3 | EndotoxinsIBA
12/2019
-
01/2012 |
3 | Oxygen (Dioxygen)IBA
12/2019
-
12/2009 |
3 | Nitric Oxide Synthase (NO Synthase)IBA
12/2019
-
08/2002 |
3 | Phenylephrine (Neo-Synephrine)FDA LinkGeneric
10/2019
-
08/2004 |
3 | CreatinineIBA
01/2019
-
10/2009 |
3 | Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA
08/2017
-
12/2008 |
3 | Cytochrome P-450 CYP2J2 (CYP2J2)IBA
01/2017
-
10/2010 |
3 | salicylhydroxamic acid (SHAM)IBA
01/2017
-
03/2010 |
3 | OxylipinsIBA
01/2017
-
01/2017 |
3 | AdiponectinIBA
01/2015
-
12/2008 |
3 | formamidine (formamidinium)IBA
03/2009
-
11/2005 |
2 | Cisplatin (Platino)FDA LinkGeneric
03/2021
-
08/2013 |
2 | Therapeutic UsesIBA
03/2021
-
12/2010 |
2 | NitrogenIBA
12/2019
-
01/2012 |
2 | BradykininIBA
12/2019
-
12/2011 |
2 | erucylphosphocholineIBA
01/2019
-
03/2014 |
2 | Fatty Acids (Saturated Fatty Acids)IBA
01/2019
-
02/2008 |